Please try another search
MyoKardia, Inc., a clinical stage biopharmaceutical company, discovers, develops, and sells targeted therapies for the treatment of serious cardiovascular diseases. The company was incorporated in 2012 and is based in Brisbane, California. As of November 16, 2020, MyoKardia, Inc. operates as a subsidiary of Bristol-Myers Squibb Company.
Are you sure you want to block %USER_NAME%?
By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.
%USER_NAME% was successfully added to your Block List
Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.
I feel that this comment is:
Thank You!
Your report has been sent to our moderators for review